Company Info
Phone(609) 495-2200
Year Established
1996
Ticker
PTN
Exchange
NYSE
Contacts
James HattersleySenior VP, Business Development
Carl Spana, Ph.D.
Co-Founder, President & CEO
Stephen T. Wills, C.P.A., M.S.T.
CFO & COO
Stephen Slusher
CLO
Michael B. Raizman, M.D.
CMO
Company Description
Palatin is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.